DirectorsTalk

Be sure to check our website

  • Home
    • Search
  • Market News
    • Automotive Services
    • Business and Support Services
    • FinTech
    • Financials & Property
    • General Retail
    • Industrials
    • Mining and Metals
    • New Energy
    • Oil and Gas
    • Pharma & Healthcare
    • Technology, Media and Telecoms
  • Interviews
  • Presentations
  • Funds
  • BrokerTalk
  • Q & A’s
  • Research
    • Hardman Research
  • Add Your News
Menu
  • Home
    • Search
  • Market News
    • Automotive Services
    • Business and Support Services
    • FinTech
    • Financials & Property
    • General Retail
    • Industrials
    • Mining and Metals
    • New Energy
    • Oil and Gas
    • Pharma & Healthcare
    • Technology, Media and Telecoms
  • Interviews
  • Presentations
  • Funds
  • BrokerTalk
  • Q & A’s
  • Research
    • Hardman Research
  • Add Your News

ORPH

Open Orphan plans for possible spin out of non-core assets
Open Orphan plans for possible spin out of non-core assets
Amilia Stone13th April 2021
Dublin-listed pharmaceutical services company Open Orphan said it is planning for a possible spin-out of some of its non-core development intellectual property assets. The company said it believed the assets in question...
Open Orphan monetisation of some of non-core assets
Open Orphan monetisation of some of non-core assets
Amilia Stone13th April 2021
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that it is...
Open Orphan’s hVIVO launches its Disease in Motion platform
Open Orphan’s hVIVO launches its Disease in Motion platform
Amilia Stone9th April 2021
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that hVIVO, a subsidiary...
First volunteers on COVID-19 human challenge study leave quarantine
First volunteers on COVID-19 human challenge study leave quarantine
Amilia Stone1st April 2021
The UK’s COVID-19 human challenge study has reached its first milestone after administering virus to three volunteers in a controlled clinical setting The first participants recruited to the landmark trial have now completed...
Cathal Friel’s Open Orphan mulls Imutex cash-in
Cathal Friel’s Open Orphan mulls Imutex cash-in
Amilia Stone29th March 2021
Speculation is mounting that Open Orphan, a clinical trial company headed by Irish dealmaker Cathal Friel, will move to spin off its stake in vaccine developer Imutex via a Nasdaq...
Open Orphan subsidiary wins €7.5m contract to run study
Open Orphan subsidiary wins €7.5m contract to run study
Amilia Stone26th March 2021
Dublin-listed pharmaceutical services company Open Orphan’s subsidiary Hvivo has won a contract worth €7.5 million to run a human viral challenge study. Open Orphan, a European-focused, rare and orphan drug consulting services...
Open Orphan’s hVIVO secures £7.5m RSV Human Challenge Study contract
Open Orphan’s hVIVO secures £7.5m RSV Human Challenge Study contract
Amilia Stone26th March 2021
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that hVIVO, a subsidiary...
Open Orphan first three volunteers in the COVID-19 characterisation study have now successfully completed the quarantine phase
Open Orphan first three volunteers in the COVID-19 characterisation study have now successfully completed the quarantine phase
Amilia Stone25th March 2021
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced an update in the...
“It’s the right thing to do” as a coronavirus human challenge trial volunteer
“It’s the right thing to do” as a coronavirus human challenge trial volunteer
Amilia Stone24th March 2021
Britain is the first country in the world to launch the Human Challenge study, which will require up to 90 volunteers aged 18 to 30 years being exposed to coronavirus...
Codagenix expands senior management team to support COVID-19 vaccine progress
Codagenix expands senior management team to support COVID-19 vaccine progress
Amilia Stone18th March 2021
Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced the expansion of its senior management team with three new appointments. Lisa Runco, Ph.D., has been...

Posts navigation

1 2 … 16 Next

Interviews

Touchstone Exploration positive flowback testing of the Cascadura Deep-1 well (Interview)
Touchstone Exploration positive flowback testing of the Cascadura Deep-1...
13th April 2021
Touchstone Exploration Inc. (LON:TXP) CEO Paul...
Dekel Agri-Vision delivering best ever month of production (Interview)
Dekel Agri-Vision delivering best ever month of production (Interview)
13th April 2021
Dekel Agri-Vision plc (LON:DKL) Executive Director...
Lookers Plc increased volumes despite lockdowns (Analyst Interview)
Lookers Plc increased volumes despite lockdowns (Analyst Interview)
13th April 2021
Lookers plc (LON:LOOK) is the topic...
Falanx Group: Breaching the defences. Attack 2: Phishing
Falanx Group: Breaching the defences. Attack 2: Phishing
12th April 2021
In the second podcast with...
Ilika Scale up of Goliath technology with Comau (Interview)
Ilika Scale up of Goliath technology with Comau (Interview)
7th April 2021
Ilika plc (LON:IKA) CEO Graeme Purdy...

Funds

Premier Miton Investors Q&A: Smaller cap & microcaps don’t just survive, they can thrive (LON:PMI)
Premier Miton Investors Q&A: Smaller cap & microcaps don’t just survive, they can thrive (LON:PMI)
13th April 2021
BlackRock Frontiers Investment Trust NAV returned +3.2% outperforming its benchmark
BlackRock Frontiers Investment Trust NAV returned +3.2% outperforming its benchmark
12th April 2021
BlackRock Frontiers Investment Trust portfolio update
BlackRock Frontiers Investment Trust portfolio update
8th April 2021
BlackRock Energy and Resources Income Trust portfolio update
BlackRock Energy and Resources Income Trust portfolio update
8th April 2021
Premier Miton Group AuM grew by 19% to £12.6 billion
Premier Miton Group AuM grew by 19% to £12.6 billion
8th April 2021
BlackRock Latin American Investment Trust declares first quarterly interim dividend
BlackRock Latin American Investment Trust declares first quarterly interim dividend
6th April 2021

Presentations

Miton UK Microcap Trust plc Presentation
Miton UK Microcap Trust plc Presentation
30th October 2020
Miton UK MicroCap Trust plc (LON:MINI)...
Touchstone Exploration Corporation Presentation September 2020
Touchstone Exploration Corporation Presentation September 2020
11th September 2020
Driving growth, profitability and responsibility...
Ferro-Alloy Resources Corporate Presentation July 2020
Ferro-Alloy Resources Corporate Presentation July 2020
23rd July 2020
Ferro-Alloy Resources ltd (LON:FAR) CEO Nicholas...
Zotefoams Mello Investor Presentation July 2020
Zotefoams Mello Investor Presentation July 2020
13th July 2020
Zotefoams plc (LON:ZTF) Group CEO David...
Blencowe Resources CEO Mike Ralston Orom-Cross jumbo graphite project presentation
Blencowe Resources CEO Mike Ralston Orom-Cross jumbo graphite project...
8th July 2020
Blencowe Resources plc (LON:BRES) CEO Mike...

Broker Talk

Cerillion plc well positioned in buoyant telecom market (LON:CER)
Cerillion plc well positioned in buoyant telecom market (LON:CER)
5th March 2021
Escape Hunt’s “digital and remote products are likely to see continued strong demand after the pandemic” says Zeus Capital
Escape Hunt’s “digital and remote products are likely to see continued strong demand after the pandemic” says Zeus Capital
22nd December 2020
Redde Northgate “robust H1 performance” says Zeus Capital
Redde Northgate “robust H1 performance” says Zeus Capital
16th December 2020
Purplebricks Group interims prompt Zeus Capital upgrades
Purplebricks Group interims prompt Zeus Capital upgrades
16th December 2020
OnTheMarket “we expect revenues to grow strongly in 2021/22” says Zeus Capital
OnTheMarket “we expect revenues to grow strongly in 2021/22” says Zeus Capital
15th December 2020
Marshall Motor Holdings: Driving through lockdown 2.0
Marshall Motor Holdings: Driving through lockdown 2.0
11th December 2020
DirectorsTalk

© 2021 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited